Breaking News Instant updates and real-time market news.

CELG

Celgene

$140.01

-6.51 (-4.44%)

07:59
10/06/17
10/06
07:59
10/06/17
07:59

Celgene drug looks 'highly competitive' in Crohn's disease, says RBC Capital

RBC Capital analyst Brian Abrahams said a just released ACG2017 abstract supports his belief that ozanimod could be "highly competitive" in Crohn's disease, which he thinks has been an underappreciated additional indication for the drug with most focus on ulcerative colitis and multiple sclerosis. The analyst, who sees $2.8B in out-year revenue potential for ozanimod in a Crohn's disease indication, keeps a Top Pick rating on Celgene shares.

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 08

    Nov

CELG Celgene
$140.01

-6.51 (-4.44%)

10/05/17
MSCO
10/05/17
DOWNGRADE
Target $120
MSCO
Underweight
Celgene downgraded to Underweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Matthew Harrison downgraded Celgene to Underweight and maintained a $120 price target given underappreciated generic risk and a cautious view on 2018 pipeline potential. The analyst said consensus is modeling a full entry of Revlimid generics in 2026, but he believes the potential for a full generic launch is much sooner, starting with a potential IPR filing by Dr. Reddy's by October 2020. Harrison said this would refocus consensus on Revlimid IP loss sooner than expected and have a -15-20% impact on Celgene.
10/02/17
LEER
10/02/17
NO CHANGE
Target $160
LEER
Outperform
Celgene growth drivers appear in place to mid-2020s, says Leerink
After meeting with several members of Celgene's senior management team, Leerink analyst Geoffrey Porges says growth drivers appear to be in place to mid-2020s. The analyst also notes that Celgene's management stated that lessons learned from Otezla's launch in psoriatic arthritis will help them better navigate the payer and contracting landscapes in upcoming Inflammation and Immunology drug launches. Porges reiterates an Outperform rating and $160 price target on the shares.
09/20/17
JEFF
09/20/17
NO CHANGE
Target $160
JEFF
Buy
Jefferies sees Celgene shares 'grinding' higher into 2018
Commentary from partner Acceleron Pharma's (XLRN) R&D day indicates Celgene (CELG) will announce lots of data in 2018, Jefferies analyst Michael Yee tells investors in a research note. He sees Celgene shares "grinding higher" over the next few months and into 2018 ahead of three major Phase III datasets: GED-301 in Crohn's, Ozanimod in ulcerative colitis and partner Acceleron's luspatercept in beta-thalassemia. The analyst keeps a Buy rating on Celgene with a $160 price target.
09/14/17
RBCM
09/14/17
INITIATION
Target $176
RBCM
Top Pick
Celgene initiated with a Top Pick at RBC Capital
RBC Capital analyst Brian Abrahams started Celgene with a Top Pick rating and $176 price target. The company's "best-in-class medium-term growth prospects are substantially undervalued relative to peers," the analyst tells investors in a research note.

TODAY'S FREE FLY STORIES

WEN

Wendy's

$16.22

0.12 (0.75%)

09:47
02/22/18
02/22
09:47
02/22/18
09:47
Hot Stocks
Wendy's says testing expanded value menu »

Says raised menu prices…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 07

    Mar

  • 30

    May

TMUS

T-Mobile

$59.42

-1.09 (-1.80%)

, DTEGY

Deutsche Telekom

$16.20

-0.07 (-0.43%)

09:47
02/22/18
02/22
09:47
02/22/18
09:47
Hot Stocks
Deutsche Telekom buys 230K shares of T-Mobile common stock »

In a regulatory filing,…

TMUS

T-Mobile

$59.42

-1.09 (-1.80%)

DTEGY

Deutsche Telekom

$16.20

-0.07 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 26

    Feb

  • 26

    Feb

  • 05

    Mar

LEXEB

Liberty Expedia Holdings

09:45
02/22/18
02/22
09:45
02/22/18
09:45
Hot Stocks
Breaking Hot Stocks news story on Liberty Expedia Holdings  »

Liberty Expedia Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OC

Owens Corning

09:45
02/22/18
02/22
09:45
02/22/18
09:45
Recommendations
Owens Corning analyst commentary  »

Owens Corning price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
02/22/18
02/22
09:45
02/22/18
09:45
General news
U.S. leading indicators preview: »

U.S. leading indicators…

09:45
02/22/18
02/22
09:45
02/22/18
09:45
General news
Breaking General news story  »

New York Federal Reserve…

09:45
02/22/18
02/22
09:45
02/22/18
09:45
General news
Leading Indicators to be reported at 10:00 »

January Leading…

SNAP

Snap

09:43
02/22/18
02/22
09:43
02/22/18
09:43
Hot Stocks
Snap slips after Kylie Jenner critique »

Early weakness in shares…Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 07

    Mar

STMP

Stamps.com

$184.95

-5.1 (-2.68%)

09:43
02/22/18
02/22
09:43
02/22/18
09:43
Recommendations
Stamps.com analyst commentary  »

Stamps.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 11

    Mar

  • 23

    May

PG

Procter & Gamble

09:42
02/22/18
02/22
09:42
02/22/18
09:42
Hot Stocks
Procter & Gamble: 'Progress will not come in a straight line' »

Says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 07

    Mar

HST

Host Hotels

, AOBC

American Outdoor Brands

$10.06

-0.12 (-1.18%)

09:40
02/22/18
02/22
09:40
02/22/18
09:40
Options
Unusually active option classes on open February 22nd »

Unusual total active…

HST

Host Hotels

AOBC

American Outdoor Brands

$10.06

-0.12 (-1.18%)

NXPI

NXP Semiconductors

$125.60

0.04 (0.03%)

TMUS

T-Mobile

$59.42

-1.09 (-1.80%)

CHK

Chesapeake

P

Pandora

WMT

Walmart

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 23

    Feb

  • 23

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 01

    Mar

  • 05

    Mar

  • 07

    Mar

  • 18

    Mar

  • 22

    Mar

  • 23

    Mar

  • 27

    Mar

  • 28

    Mar

LMFA

LM Funding

$1.51

0.08 (5.59%)

, LFIN

Longfin

$34.20

-2.03 (-5.60%)

09:38
02/22/18
02/22
09:38
02/22/18
09:38
Periodicals
LM Funding takeover rumors discussed in web report »

The "GrooveVC"…

LMFA

LM Funding

$1.51

0.08 (5.59%)

LFIN

Longfin

$34.20

-2.03 (-5.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTS

QTS Realty Trust

09:37
02/22/18
02/22
09:37
02/22/18
09:37
Recommendations
QTS Realty Trust analyst commentary  »

QTS Realty Trust price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 04

    Mar

  • 05

    Mar

  • 15

    Mar

  • 03

    Apr

FSLR

First Solar

09:36
02/22/18
02/22
09:36
02/22/18
09:36
Downgrade
First Solar rating change  »

First Solar downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 15

    Mar

AVGO

Broadcom

$248.62

-1 (-0.40%)

, QCOM

Qualcomm

$63.40

-0.59 (-0.92%)

09:36
02/22/18
02/22
09:36
02/22/18
09:36
Recommendations
Broadcom, Qualcomm, Xilinx, Analog Devices, Maxim Integrated, Marvell, Microsemi analyst commentary  »

RBC finds takeover…

AVGO

Broadcom

$248.62

-1 (-0.40%)

QCOM

Qualcomm

$63.40

-0.59 (-0.92%)

XLNX

Xilinx

$68.46

-0.73 (-1.06%)

ADI

Analog Devices

MXIM

Maxim Integrated

$61.75

-0.37 (-0.60%)

MRVL

Marvell

$23.19

-0.01 (-0.04%)

MSCC

Microsemi

$60.94

-0.52 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 06

    Mar

  • 08

    Mar

  • 22

    Mar

IDGX

AltheaDx

09:35
02/22/18
02/22
09:35
02/22/18
09:35
Initiation
AltheaDx initiated  »

AltheaDx initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFM

Sprouts Farmers Market

$26.12

0.12 (0.46%)

09:34
02/22/18
02/22
09:34
02/22/18
09:34
Earnings
Sprouts Farmers Market sees FY18 EPS $1.22-$1.28, consensus $1.23 »

Sees FY18 revenue up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

SFM

Sprouts Farmers Market

$26.12

0.12 (0.46%)

09:33
02/22/18
02/22
09:33
02/22/18
09:33
Earnings
Sprouts Farmers Market reports Q4 EPS 29c, consensus 15c »

Reports Q4 revenue $1.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

NNBR

NN, Inc.

$25.40

0.25 (0.99%)

09:32
02/22/18
02/22
09:32
02/22/18
09:32
Hot Stocks
NN, Inc. acquires Bridgemedica, terms not disclosed »

NN announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

SHPG

Shire

$125.03

-1.64 (-1.29%)

09:31
02/22/18
02/22
09:31
02/22/18
09:31
Recommendations
Shire analyst commentary  »

Shire post results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 23

    Mar

  • 25

    Mar

09:30
02/22/18
02/22
09:30
02/22/18
09:30
General news
U.S. equities are mildly firmer »

U.S. equities are mildly…

AYX

Alteryx

09:30
02/22/18
02/22
09:30
02/22/18
09:30
Recommendations
Alteryx analyst commentary  »

Alteryx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
02/22/18
02/22
09:30
02/22/18
09:30
General news
Breaking General news story  »

Week of 2/18 Bloomberg…

WEX

Wex

09:28
02/22/18
02/22
09:28
02/22/18
09:28
Recommendations
Wex analyst commentary  »

Wex price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

APLS

Apellis

$14.77

0.13 (0.89%)

09:27
02/22/18
02/22
09:27
02/22/18
09:27
Hot Stocks
Apellis announces 18-month results of Phase 2 study of APL-2 »

Apellis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.